Shares of Chemours Co (NYSE:CC) gapped down prior to trading on Monday . The stock had previously closed at $16.08, but opened at $16.90. Chemours shares last traded at $17.29, with a volume of 65,317 shares changing hands.
A number of equities research analysts have issued reports on CC shares. Cfra raised Chemours from a “hold” rating to a “buy” rating in a research report on Wednesday, November 6th. SunTrust Banks increased their price objective on Chemours to $20.00 and gave the company a “hold” rating in a report on Wednesday, November 6th. ValuEngine upgraded Chemours from a “sell” rating to a “hold” rating in a report on Friday, January 3rd. UBS Group dropped their price objective on Chemours from $19.00 to $14.50 and set a “neutral” rating on the stock in a report on Wednesday, October 2nd. Finally, JPMorgan Chase & Co. dropped their price objective on Chemours from $21.00 to $19.00 and set a “neutral” rating on the stock in a report on Friday, December 20th. Nine investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Chemours presently has a consensus rating of “Hold” and an average target price of $25.77.
The firm has a market cap of $2.78 billion, a PE ratio of 3.01, a P/E/G ratio of 0.35 and a beta of 2.55. The company has a current ratio of 1.72, a quick ratio of 0.98 and a debt-to-equity ratio of 5.05. The business has a fifty day moving average price of $16.99 and a 200 day moving average price of $16.91.
Chemours (NYSE:CC) last released its quarterly earnings data on Monday, November 4th. The specialty chemicals company reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.56 by $0.03. Chemours had a return on equity of 58.38% and a net margin of 7.24%. The business had revenue of $1.39 billion for the quarter, compared to the consensus estimate of $1.40 billion. During the same quarter in the prior year, the business posted $1.49 EPS. The business’s revenue for the quarter was down 14.6% on a year-over-year basis. On average, research analysts expect that Chemours Co will post 2.37 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Monday, December 16th. Investors of record on Friday, November 15th were paid a dividend of $0.25 per share. The ex-dividend date of this dividend was Thursday, November 14th. This represents a $1.00 dividend on an annualized basis and a yield of 5.85%. Chemours’s dividend payout ratio is presently 17.64%.
Large investors have recently added to or reduced their stakes in the stock. Point72 Hong Kong Ltd purchased a new position in Chemours during the 2nd quarter worth approximately $29,000. Parallel Advisors LLC grew its stake in Chemours by 479.4% during the 3rd quarter. Parallel Advisors LLC now owns 2,312 shares of the specialty chemicals company’s stock worth $35,000 after buying an additional 1,913 shares during the last quarter. Quadrant Capital Group LLC grew its stake in Chemours by 423.4% during the 3rd quarter. Quadrant Capital Group LLC now owns 2,727 shares of the specialty chemicals company’s stock worth $36,000 after buying an additional 2,206 shares during the last quarter. Oppenheimer Asset Management Inc. grew its stake in Chemours by 41.7% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 3,782 shares of the specialty chemicals company’s stock worth $56,000 after buying an additional 1,113 shares during the last quarter. Finally, Synovus Financial Corp grew its stake in Chemours by 168.0% during the 3rd quarter. Synovus Financial Corp now owns 3,988 shares of the specialty chemicals company’s stock worth $59,000 after buying an additional 2,500 shares during the last quarter. Hedge funds and other institutional investors own 76.22% of the company’s stock.
About Chemours (NYSE:CC)
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging.